Neurological outcome and inflammation after cardiac arrest-Effects of protein C in rats

Resuscitation

Volumn 79, Issue 2, 2008, Pages 316-324

  Teschendorf, Peter ^a,b   Albertsmeier, Markus ^b,c   Vogel, Peter ^b   Padosch, Stephan A ^a,b   Spöhr, Fabian ^a,b   Kirschfink, Michael ^b   Schwaninger, Markus ^b   Böttiger, Bernd W ^a,b   Popp, Erik ^b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cardiac arrest; Cardiopulmonary resuscitation (CPR); Cerebral ischaemia; Drotrecogin alfa activated; Inflammatory response; Neurological dysfunction; Rats

Indexed keywords

CASPASE; DROTRECOGIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; PLACEBO; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; ENZYME ACTIVITY; HEART ARREST; HIPPOCAMPUS; HISTOPATHOLOGY; INFLAMMATION; LOW DRUG DOSE; MALE; NEUROLOGIC DISEASE; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; RAT; RESUSCITATION; SCORING SYSTEM; TREATMENT OUTCOME;

ANIMALS; ANTI-INFECTIVE AGENTS; BEHAVIOR, ANIMAL; BRAIN; CARDIOPULMONARY RESUSCITATION; CASPASES; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART ARREST; MALE; PROTEIN C; RATS; RATS, WISTAR; RECOMBINANT PROTEINS;

EID: 54049128844     PISSN: 03009572     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resuscitation.2008.05.005     Document Type: Article

References (34)

1. Rea T.D., Eisenberg M.S., Sinibaldi G., and White R.D. Incidence of EMS-treated out-of-hospital cardiac arrest in the United States. Resuscitation 63 (2004) 17-24
2. Böttiger B.W., Grabner C., Bauer H., et al. Long term outcome after out-of-hospital cardiac arrest with physician staffed emergency medical services: the Utstein style applied to a midsized urban/suburban area. Heart 82 (1999) 674-679
3. Roine R.O., Kajaste S., and Kaste M. Neuropsychological sequelae of cardiac arrest. JAMA 269 (1993) 237-242
4. Bernard S.A., Gray T.W., Buist M.D., et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 346 (2002) 557-563
5. The Hypothermia After Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 346 (2002) 549-556
6. Böttiger B.W., Motsch J., Bohrer H., et al. Activation of blood coagulation after cardiac arrest is not balanced adequately by activation of endogenous fibrinolysis. Circulation 92 (1995) 2572-2578
7. Böttiger B.W., Motsch J., Braun V., Martin E., and Kirschfink M. Marked activation of complement and leukocytes and an increase in the concentrations of soluble endothelial adhesion molecules during cardiopulmonary resuscitation and early reperfusion after cardiac arrest in humans. Crit Care Med 30 (2002) 2473-2480
8. Adrie C., Adib-Conquy M., Laurent I., et al. Successful cardiopulmonary resuscitation after cardiac arrest as a "sepsis-like" syndrome. Circulation 106 (2002) 562-568
9. Adrie C., Monchi M., Laurent I., et al. Coagulopathy after successful cardiopulmonary resuscitation following cardiac arrest: implication of the protein C anticoagulant pathway. J Am Coll Cardiol 46 (2005) 21-28
10. Macias W.L., and Nelson D.R. Severe protein C deficiency predicts early death in severe sepsis. Crit Care Med 32 (2004) S223-S228
11. Bernard G.R., Vincent J.L., Laterre P.F., et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344 (2001) 699-709
12. Grey S., Tsuchida A., Hau H., Orthner C., Salem H., and Hancock W. Selective inhibitory effects of the anticoagulant activated protein C on the responses of human mononuclear phagocytes to LPS, IFN-gamma, or phorbol ester. J Immunol 153 (1994) 3664-3672
13. Joyce D.E., Gelbert L., Ciaccia A., DeHoff B., and Grinnell B.W. Gene expression profile of antithrombotic protein C defines new mechanisms modulating inflammation and apoptosis. J Biol Chem 276 (2001) 11199-11203
14. Brückmann M., Horn S., Lang S., et al. Recombinant human activated protein C upregulates cyclooxygenase-2 expression in endothelial cells via binding to endothelial cell protein C receptor and activation of protease-activated receptor-1. Thromb Haemost 93 (2005) 743-750
15. Fukudome K., and Esmon C.T. Identification, cloning, and regulation of a novel endothelial cell protein C/activated protein C receptor. J Biol Chem 269 (1994) 26486-26491
16. Riewald M., Petrovan R.J., Donner A., Mueller B.M., and Ruf W. Activation of endothelial cell protease activated receptor 1 by the protein C pathway. Science 296 (2002) 1880-1882
17. Ruf W. Protease-activated receptor signaling in the regulation of inflammation. Crit Care Med 32 (2004) S287-S292
18. Hoffmann J.N., Vollmar B., Laschke M.W., et al. Microhemodynamic and cellular mechanisms of activated protein C action during endotoxemia. Crit Care Med 32 (2004) 1011-1017
19. Murakami K., Okajima K., Uchiba M., et al. Activated protein C attenuates endotoxin-induced pulmonary vascular injury by inhibiting activated leukocytes in rats. Blood 87 (1996) 642-647
20. Schoots I.G., Levi M., van Vliet A.K., Maas A.M., Roossink E.H., and van Gulik T.M. Inhibition of coagulation and inflammation by activated protein C or antithrombin reduces intestinal ischemia/reperfusion injury in rats. Crit Care Med 32 (2004) 1375-1383
21. Taoka Y., Okajima K., Uchiba M., et al. Activated protein C reduces the severity of compression-induced spinal cord injury in rats by inhibiting activation of leukocytes. J Neurosci 18 (1998) 1393-1398
22. Mizutani A., Okajima K., Uchiba M., and Noguchi T. Activated protein C reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation. Blood 95 (2000) 3781-3787
23. Shibata M., Kumar S.R., Amar A., et al. Anti-inflammatory, antithrombotic, and neuroprotective effects of activated protein C in a murine model of focal ischemic stroke. Circulation 103 (2001) 1799-1805
24. Cheng T., Liu D., Griffin J.H., et al. Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective. Nat Med 9 (2003) 338-342
25. Schallert T., Upchurch M., Lobaugh N., et al. Tactile extinction: distinguishing between sensorimotor and motor asymmetries in rats with unilateral nigrostriatal damage. Pharmacol Biochem Behav 16 (1982) 455-462
26. Albertsmeier M., Teschendorf P., Popp E., Galmbacher R., Vogel P., and Bottiger B.W. Evaluation of a tape removal test to assess neurological deficit after cardiac arrest in rats. Resuscitation 74 (2007) 552-558
27. Katz L., Ebmeyer U., Safar P., Radovsky A., and Neumar R. Outcome model of asphyxial cardiac arrest in rats. J Cereb Blood Flow Metab 15 (1995) 1032-1039
28. Neumar R.W., Bircher N.G., Sim K.M., et al. Epinephrine and sodium bicarbonate during CPR following asphyxial cardiac arrest in rats. Resuscitation 29 (1995) 249-263
29. Gavrieli Y., Sherman Y., and Ben-Sasson S.A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119 (1992) 493-501
30. Jackson C.V., Bailey B.D., and Shetler T.J. Pharmacological profile of recombinant, human activated protein C (LY203638) in a canine model of coronary artery thrombosis. J Pharmacol Exp Ther 295 (2000) 967-971
31. Walker F.J. Regulation of bovine activated protein C by protein S: the role of the cofactor protein in species specificity. Thromb Res 22 (1981) 321-327
32. Arnljots B., and Dahlbäck B. Protein S as an in vivo cofactor to activated protein C in prevention of microarterial thrombosis in rabbits. J Clin Invest 95 (1995) 1987-1993
33. Derhaschnig U., Reiter R., Knobl P., Baumgartner M., Keen P., and Jilma B. Recombinant human activated protein C (rhAPC; drotrecogin alfa [activated]) has minimal effect on markers of coagulation, fibrinolysis, and inflammation in acute human endotoxemia. Blood 102 (2003) 2093-2098
34. Abraham E., Laterre P.F., Garg R., et al. Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. N Engl J Med 353 (2005) 1332-1341